Joanna Merckx1, Jeremy A Labrecque2, Jay S Kaufman1. 1. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada 2. Department of Epidemiology, Erasmus Medical Center, Rotterdam, Netherlands.
Abstract
BACKGROUND: Six months into the COVID-19 pandemic, children appear largely spared from the direct effects of disease, suggesting age as an important predictor of infection and severity. They remain, however, impacted by far-reaching public health interventions. One crucial question often posed is whether children generally transmit SARS-CoV-2 effectively. METHODS: We assessed the components of transmission and the different study designs and considerations necessary for valid assessment of transmission dynamics. We searched for published evidence about transmission of SARS-CoV-2 by children employing a narrative review methodology through 25 June, 2020. RESULTS: Transmission dynamics must be studied in repre - sentative pediatric populations with a combination of study designs including rigorous epidemiological studies (e.g. in households, schools, daycares, clinical settings) and laboratory studies while taking into account the social and socio-economic contexts. Viral load (VL) estimates from representative pediatric samples of infected children are missing so far. Currently available evidence suggests that the secondary attack rate stratified by age of the infector is lower for children, however this age pattern needs to be better quantified and understood. CONCLUSION: A generalizable pediatric evidence base is urgently needed to inform policy making now, later when facing potential subsequent waves, and extending through a future in which endemicity alongside vaccination may become the enduring reality.
BACKGROUND: Six months into the COVID-19 pandemic, children appear largely spared from the direct effects of disease, suggesting age as an important predictor of infection and severity. They remain, however, impacted by far-reaching public health interventions. One crucial question often posed is whether children generally transmit SARS-CoV-2 effectively. METHODS: We assessed the components of transmission and the different study designs and considerations necessary for valid assessment of transmission dynamics. We searched for published evidence about transmission of SARS-CoV-2 by children employing a narrative review methodology through 25 June, 2020. RESULTS: Transmission dynamics must be studied in repre - sentative pediatric populations with a combination of study designs including rigorous epidemiological studies (e.g. in households, schools, daycares, clinical settings) and laboratory studies while taking into account the social and socio-economic contexts. Viral load (VL) estimates from representative pediatric samples of infectedchildren are missing so far. Currently available evidence suggests that the secondary attack rate stratified by age of the infector is lower for children, however this age pattern needs to be better quantified and understood. CONCLUSION: A generalizable pediatric evidence base is urgently needed to inform policy making now, later when facing potential subsequent waves, and extending through a future in which endemicity alongside vaccination may become the enduring reality.
Authors: Fiona P Havers; Carrie Reed; Travis Lim; Joel M Montgomery; John D Klena; Aron J Hall; Alicia M Fry; Deborah L Cannon; Cheng-Feng Chiang; Aridth Gibbons; Inna Krapiunaya; Maria Morales-Betoulle; Katherine Roguski; Mohammad Ata Ur Rasheed; Brandi Freeman; Sandra Lester; Lisa Mills; Darin S Carroll; S Michele Owen; Jeffrey A Johnson; Vera Semenova; Carina Blackmore; Debra Blog; Shua J Chai; Angela Dunn; Julie Hand; Seema Jain; Scott Lindquist; Ruth Lynfield; Scott Pritchard; Theresa Sokol; Lynn Sosa; George Turabelidze; Sharon M Watkins; John Wiesman; Randall W Williams; Stephanie Yendell; Jarad Schiffer; Natalie J Thornburg Journal: JAMA Intern Med Date: 2020-07-21 Impact factor: 21.873
Authors: Russell M Viner; Oliver T Mytton; Chris Bonell; G J Melendez-Torres; Joseph Ward; Lee Hudson; Claire Waddington; James Thomas; Simon Russell; Fiona van der Klis; Archana Koirala; Shamez Ladhani; Jasmina Panovska-Griffiths; Nicholas G Davies; Robert Booy; Rosalind M Eggo Journal: JAMA Pediatr Date: 2021-02-01 Impact factor: 16.193
Authors: Paul L Delamater; Erica J Street; Timothy F Leslie; Y Tony Yang; Kathryn H Jacobsen Journal: Emerg Infect Dis Date: 2019-01 Impact factor: 6.883
Authors: Neeltje van Doremalen; Trenton Bushmaker; Dylan H Morris; Myndi G Holbrook; Amandine Gamble; Brandi N Williamson; Azaibi Tamin; Jennifer L Harcourt; Natalie J Thornburg; Susan I Gerber; James O Lloyd-Smith; Emmie de Wit; Vincent J Munster Journal: N Engl J Med Date: 2020-03-17 Impact factor: 91.245
Authors: Julio C Soto; Mireille Barakat; Juliana Ayres Hutter; Marilou Kiely; Sandrine Moreira; B Jesse Shapiro; Carmen Lia Murall; Nicolas Parenteau; Joane Désilets; Richard Lessard Journal: Can J Public Health Date: 2021-05-28
Authors: Malte Kohns Vasconcelos; Hanna Renk; Jolanta Popielska; Maggie Nyirenda Nyang'wa; Sigita Burokiene; Despoina Gkentzi; Ewelina Gowin; Daniele Donà; Sara Villanueva-Medina; Andrew Riordan; Markus Hufnagel; Sarah Eisen; Liviana Da Dalt; Carlo Giaquinto; Julia A Bielicki Journal: Eur J Pediatr Date: 2020-10-13 Impact factor: 3.183
Authors: Franziska Hommes; Welmoed van Loon; Marlene Thielecke; Igor Abramovich; Sascha Lieber; Ralf Hammerich; Sabine Gehrke-Beck; Elisabeth Linzbach; Angela Schuster; Katja von dem Busche; Stefanie Theuring; Maximilian Gertler; Gabriela Equihua Martinez; Joachim Richter; Clara Bergmann; Alisa Bölke; Falko Böhringer; Marcus A Mall; Alexander Rosen; Alexander Krannich; Jan Keller; Norma Bethke; Marco Kurzmann; Tobias Kurth; Valerie Kirchberger; Joachim Seybold; Frank P Mockenhaupt; Becoss Study Group Journal: Int J Environ Res Public Health Date: 2021-03-08 Impact factor: 3.390